GPGrossPatternRESEARCH SYSTEM
SEC CHECK OPERATIONAL
GROSSPATTERN / FUNDAMENTAL STATE / POINT IN TIME

ENSC · Mar 31, 2026

Ensysce Biosciences, Inc.. A multidimensional configuration derived from the filing available at this observation—never a composite score or recommendation.

STATE CAPABILITYLEVEL 3[email protected]
Inspectable configuration

State dimensions

Filing0001493152-26-023811General Corporate
Operating cash generation67thOwn-history percentile · N=15
Evidence method

Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue

-364.30% · OPTIONAL · VALID

Revenue growth27thOwn-history percentile · N=11
Evidence method

Yoy · gp.fundamentals.revenue

-27.18% · CORE · VALID

Operating margin60thOwn-history percentile · N=15
Evidence method

Level · gp.fundamentals.operating_margin

-370.68% · CORE · VALID

R&D intensity60thOwn-history percentile · N=15
Evidence method

Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue

348.27% · OPTIONAL · VALID

SBC intensity7thOwn-history percentile · N=15
Evidence method

Level · gp.fundamentals.sbc_revenue_ratio

0.91% · OPTIONAL · VALID

As-filed lineage

Fundamental state history

Each observation is tied to the filing and facts available at that report date. Amendments remain separate.

History13 statesSelf-history eligible
Period transition

What moved in the state?

Cash Generation Decreased
Previous
-154.07%
Current
-364.30%
Delta
-210.23%
Growth Decreased
Previous
-2.75%
Current
-27.18%
Delta
-24.43%
Profitability Decreased
Previous
-202.12%
Current
-370.68%
Delta
-168.56%
R And D Intensity Increased
Previous
204.81%
Current
348.27%
Delta
143.46%
Sbc Intensity Decreased
Previous
3.50%
Current
0.91%
Delta
-2.59%
Self-history only

Previous similar states

Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.

Not enough compatible prior states for a transparent self-history match.
Research Graph

Related governed research

Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.